Does continued alendronate therapy improve bone mineral density and reduce fracture risk in postmenopausal women?

Affiliations

Comment

Marius E Kraenzlin et al. Nat Clin Pract Endocrinol Metab. 2007 Oct.

. 2007 Oct;3(10):686-7.

doi: 10.1038/ncpendmet0618. Epub 2007 Aug 14.

¹ Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital, Basel, Switzerland. marius.kraenzlin@unibas.ch

No abstract available

Comment on

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.
Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB, Bauer DC, Palermo L, Wehren LE, Lombardi A, Santora AC, Cummings SR; FLEX Research Group. Black DM, et al. JAMA. 2006 Dec 27;296(24):2927-38. doi: 10.1001/jama.296.24.2927. JAMA. 2006. PMID: 17190893 Clinical Trial.